1-6 of 6
Roland Eils
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer

Bohai Feng, Ying Shen, Xavier Pastor Hostench, Matthias Bieg, Michaela Plath, Naveed Ishaque, Roland Eils, Kolja Freier, Wilko Weichert, Karim Zaoui, Jochen Hess
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (14): 3616–3628.
https://doi.org/10.1158/1078-0432.CCR-19-3997
Published: 15 July 2020
View article titled, Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer
Open the PDF for Integrative Analysis of Multi-omics Data Identified EGFR and PTGS2 as Key Nodes in a Gene Regulatory Network Related to Immune Phenotypes in Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response

Alexander Muckenhuber, Anne Katrin Berger, Anna Melissa Schlitter, Katja Steiger, Björn Konukiewitz, Andreas Trumpp, Roland Eils, Jens Werner, Helmut Friess, Irene Esposito, Günter Klöppel, Güralp O. Ceyhan, Moritz Jesinghaus, Carsten Denkert, Marcus Bahra, Albrecht Stenzinger, Martin R. Sprick, Dirk Jäger, Christoph Springfeld, Wilko Weichert
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (2): 351–359.
https://doi.org/10.1158/1078-0432.CCR-17-2180
Published: 15 January 2018
View article titled, Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response
Open the PDF for Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response in another window
Includes: Supplementary data
Journal Articles

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz, Rene Schmidt, Andreas Faldum, Yvonne Kahlert, Anne Engesser, Shahab Asgharzadeh, Robert Seeger, Miki Ohira, Akira Nakagawara, Paola Scaruffi, Gian Paolo Tonini, Isabelle Janoueix-Lerosey, Olivier Delattre, Gudrun Schleiermacher, Jo Vandesompele, Frank Speleman, Rosa Noguera, Marta Piqueras, Jean Bénard, Alexander Valent, Smadar Avigad, Isaac Yaniv, Richard G. Grundy, Monika Ortmann, Chunxuan Shao, Manfred Schwab, Roland Eils, Thorsten Simon, Jessica Theissen, Frank Berthold, Frank Westermann, Benedikt Brors, Matthias Fischer
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (8): 1904–1915.
https://doi.org/10.1158/1078-0432.CCR-14-0817
Published: 14 April 2015
View article titled, Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
Open the PDF for Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers in another window
Includes: Supplementary data
Journal Articles

Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR

André Oberthuer, Lars Kaderali, Yvonne Kahlert, Barbara Hero, Frank Westermann, Frank Berthold, Benedikt Brors, Roland Eils, Matthias Fischer
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6590–6601.
https://doi.org/10.1158/1078-0432.CCR-07-4377
Published: 16 October 2008
View article titled, Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR
Open the PDF for Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR in another window
Includes: Supplementary data
Journal Articles

Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome

Alexander Schramm, Jo Vandesompele, Johannes H. Schulte, Sabine Dreesmann, Lars Kaderali, Benedikt Brors, Roland Eils, Frank Speleman, Angelika Eggert
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (5): 1459–1465.
https://doi.org/10.1158/1078-0432.CCR-06-2032
Published: 01 March 2007
View article titled, Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome
Open the PDF for Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome in another window
Journal Articles

High-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of Invasive Breast Cancer

Daniel E. Stange, Bernhard Radlwimmer, Falk Schubert, Frank Traub, Andreas Pich, Grischa Toedt, Frank Mendrzyk, Ulrich Lehmann, Roland Eils, Hans Kreipe, Peter Lichter
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (2): 345–352.
https://doi.org/10.1158/1078-0432.CCR-05-1633
Published: 20 January 2006
View article titled, High-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of Invasive Breast Cancer
Open the PDF for High-Resolution Genomic Profiling Reveals Association of Chromosomal Aberrations on 1q and 16p with Histologic and Genetic Subgroups of Invasive Breast Cancer in another window